BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palma DA, Senan S, Haasbeek CJ, Verbakel WF, Vincent A, Lagerwaard F. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques. Int J Radiat Oncol Biol Phys 2011;80:506-13. [PMID: 20584582 DOI: 10.1016/j.ijrobp.2010.02.032] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Rajan Radha R, Chandrasekharan G. Pulmonary injury associated with radiation therapy - Assessment, complications and therapeutic targets. Biomed Pharmacother 2017;89:1092-104. [PMID: 28298070 DOI: 10.1016/j.biopha.2017.02.106] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
2 Arcangeli S, Agolli L, Portalone L, Migliorino MR, Lopergolo MG, Monaco A, Dognini J, Pressello MC, Bracci S, Donato V. Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC. Br J Radiol 2015;88:20140728. [PMID: 25645106 DOI: 10.1259/bjr.20140728] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
3 Bourbonne V, Delafoy A, Lucia F, Quéré G, Pradier O, Schick U. Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study. Transl Lung Cancer Res 2021;10:156-66. [PMID: 33569301 DOI: 10.21037/tlcr-20-406] [Reference Citation Analysis]
4 Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 2011;84:967-96. [PMID: 22011829 DOI: 10.1259/bjr/22373346] [Cited by in Crossref: 308] [Cited by in F6Publishing: 231] [Article Influence: 28.0] [Reference Citation Analysis]
5 Mattonen SA, Ward AD, Palma DA. Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply? Br J Radiol 2016;89:20160113. [PMID: 27245137 DOI: 10.1259/bjr.20160113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
6 Chan C, Lang S, Rowbottom C, Guckenberger M, Faivre-Finn C; IASLC Advanced Radiation Technology Committee. Intensity-modulated radiotherapy for lung cancer: current status and future developments. J Thorac Oncol 2014;9:1598-608. [PMID: 25436795 DOI: 10.1097/JTO.0000000000000346] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
7 Ishii K, Okada W, Ogino R, Kubo K, Kishimoto S, Nakahara R, Kawamorita R, Ishii Y, Tada T, Nakajima T. A treatment-planning comparison of three beam arrangement strategies for stereotactic body radiation therapy for centrally located lung tumors using volumetric-modulated arc therapy. J Radiat Res 2016;57:273-9. [PMID: 26951076 DOI: 10.1093/jrr/rrv105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Bousabarah K, Temming S, Hoevels M, Borggrefe J, Baus WW, Ruess D, Visser-Vandewalle V, Ruge M, Kocher M, Treuer H. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy. Strahlenther Onkol 2019;195:830-42. [PMID: 30874846 DOI: 10.1007/s00066-019-01452-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
9 Oh SA, Yea JW, Kim SK. Statistical Determination of the Gating Windows for Respiratory-Gated Radiotherapy Using a Visible Guiding System. PLoS One 2016;11:e0156357. [PMID: 27228097 DOI: 10.1371/journal.pone.0156357] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Huang K, Senthi S, Palma DA, Spoelstra FO, Warner A, Slotman BJ, Senan S. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiotherapy and Oncology 2013;109:51-7. [DOI: 10.1016/j.radonc.2013.06.047] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 9.2] [Reference Citation Analysis]
11 Szejniuk WM, Nielsen MS, Brønnum D, Takács-Szabó Z, Weinreich UM, Pilegaard Thomsen L, Bøgsted M, Jensen I, McCulloch T, Falkmer UG, Carl J, Røe OD. Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer: A pilot study. Clin Transl Radiat Oncol 2019;19:103-9. [PMID: 31650045 DOI: 10.1016/j.ctro.2019.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Pöttgen C, Abu Jawad J, Gkika E, Freitag L, Lübcke W, Welter S, Gauler T, Schuler M, Eberhardt WE, Stamatis G, Stuschke M. Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy. J Thorac Dis 2015;7:264-72. [PMID: 25922702 DOI: 10.3978/j.issn.2072-1439.2015.01.59] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Jiang X, Li T, Liu Y, Zhou L, Xu Y, Zhou X, Gong Y. Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc/partial-arc volumetric modulated arc therapy (SA/PA-VMAT). Radiat Oncol 2011;6:140. [PMID: 22014217 DOI: 10.1186/1748-717X-6-140] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
14 Mahadevan A, Emami B, Grimm J, Kleinberg LR, Redmond KJ, Welsh JS, Rostock R, Kemmerer E, Forster KM, Stanford J, Shah S, Asbell SO, LaCouture TA, Scofield C, Butterwick I, Xue J, Muacevic A, Adler JR. Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models. Front Oncol 2020;10:591430. [PMID: 33634020 DOI: 10.3389/fonc.2020.591430] [Reference Citation Analysis]
15 Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S. Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer. Journal of Thoracic Oncology 2011;6:1221-8. [DOI: 10.1097/jto.0b013e318219aac5] [Cited by in Crossref: 99] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
16 Ye L, Zhang Y, Li T, Zhang X, Shi S, Zhao Q, Zeng Z, He J. Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy. J Radiat Res 2019;60:371-9. [PMID: 30968939 DOI: 10.1093/jrr/rrz007] [Reference Citation Analysis]
17 Senthi S, Dahele M, van de Ven PM, Slotman BJ, Senan S. Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: A comparison of fixed-beam versus arc delivery techniques. Radiotherapy and Oncology 2013;109:77-81. [DOI: 10.1016/j.radonc.2013.08.034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
18 Chi A, Ma P, Fu G, Hobbs G, Welsh JS, Nguyen NP, Jang SY, Dai J, Jin J, Komaki R. Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy. PLoS One 2013;8:e59729. [PMID: 23577071 DOI: 10.1371/journal.pone.0059729] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
19 Menoux I, Le Fèvre C, Noël G, Antoni D. [Radiation-induced lung toxicity predictors after stereotactic radiation therapy for non-small cell lung carcinoma stage I]. Cancer Radiother 2018;22:826-38. [PMID: 30337050 DOI: 10.1016/j.canrad.2017.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes. Acta Oncol 2013;52:910-8. [PMID: 23106174 DOI: 10.3109/0284186X.2012.731525] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
21 Badellino S, Muzio JD, Schivazappa G, Guarneri A, Ragona R, Bartoncini S, Trino E, Filippi AR, Fonio P, Ricardi U. No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer. Br J Radiol 2017;90:20170143. [PMID: 28749172 DOI: 10.1259/bjr.20170143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Huang K, Palma DA; IASLC Advanced Radiation Technology Committee. Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist. J Thorac Oncol 2015;10:412-9. [PMID: 25695219 DOI: 10.1097/JTO.0000000000000435] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
23 Mix M, Tanny S, Nsouli T, Alden R, Chaudhari R, Kincaid R, Rosenbaum PF, Bogart JA, Aridgides P. Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer. Lung Cancer (Auckl) 2019;10:151-9. [PMID: 31908556 DOI: 10.2147/LCTT.S235713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Mathew L, Vandyk J, Etemad-rezai R, Rodrigues G, Parraga G. Hyperpolarized 3 He pulmonary functional magnetic resonance imaging prior to radiation therapy: Pulmonary MRI prior to radiation therapy. Med Phys 2012;39:4284-90. [DOI: 10.1118/1.4729713] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
25 Huang K, Dahele M, Senan S, Guckenberger M, Rodrigues GB, Ward A, Boldt RG, Palma DA. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol. 2012;102:335-342. [PMID: 22305958 DOI: 10.1016/j.radonc.2011.12.018] [Cited by in Crossref: 139] [Cited by in F6Publishing: 121] [Article Influence: 13.9] [Reference Citation Analysis]
26 Dağdelen M, Akovalı ES, Barlas C, Can G, Dinçbaş FÖ. Interobserver agreement between interpretations of acute changes after lung stereotactic body radiotherapy. Strahlenther Onkol 2021;197:423-8. [PMID: 33231713 DOI: 10.1007/s00066-020-01711-y] [Reference Citation Analysis]
27 Ferrero C, Badellino S, Filippi AR, Focaraccio L, Giaj Levra M, Levis M, Moretto F, Torchio R, Ricardi U, Novello S. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study. Lung Cancer 2015;89:350-6. [PMID: 26164208 DOI: 10.1016/j.lungcan.2015.06.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
28 Zhang R, Wang C, Cui K, Chen Y, Sun F, Sun X, Xing L. Prognostic Role Of Computed Tomography Textural Features In Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy. Cancer Manag Res 2019;11:9921-30. [PMID: 31819630 DOI: 10.2147/CMAR.S220587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
29 Ricardi U, Badellino S, Filippi AR. Stereotactic radiotherapy for early stage non-small cell lung cancer. Radiat Oncol J 2015;33:57-65. [PMID: 26157674 DOI: 10.3857/roj.2015.33.2.57] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
30 Chassagnon G, Martini K, Giraud P, Revel MP. Radiological assessment after stereotactic body radiation of lung tumours. Cancer Radiother 2020;24:379-87. [PMID: 32534799 DOI: 10.1016/j.canrad.2020.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Nicolini G, Ghosh-laskar S, Shrivastava SK, Banerjee S, Chaudhary S, Agarwal JP, Munshi A, Clivio A, Fogliata A, Mancosu P, Vanetti E, Cozzi L. Volumetric Modulation Arc Radiotherapy With Flattening Filter-Free Beams Compared With Static Gantry IMRT and 3D Conformal Radiotherapy for Advanced Esophageal Cancer: A Feasibility Study. International Journal of Radiation Oncology*Biology*Physics 2012;84:553-60. [DOI: 10.1016/j.ijrobp.2011.12.041] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
32 Fitzgerald R, Owen R, Hargrave C, Pryor D, Barry T, Lehman M, Bernard A, Mai T, Seshadri V, Fielding A. A comparison of three different VMAT techniques for the delivery of lung stereotactic ablative radiation therapy. J Med Radiat Sci 2016;63:23-30. [PMID: 27087972 DOI: 10.1002/jmrs.156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Glide-Hurst CK, Chetty IJ. Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies. J Thorac Dis 2014;6:303-18. [PMID: 24688775 DOI: 10.3978/j.issn.2072-1439.2013.11.10] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
34 Vulquin N, Feutray S, Peignaux-casasnovas K, Humbert O, Créhange G, Truc G, Maingon P, Martin É. Évaluation radiologique de la réponse tumorale après radiothérapie pulmonaire en conditions stéréotaxiques. Cancer/Radiothérapie 2014;18:414-9. [DOI: 10.1016/j.canrad.2014.07.157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
35 Deodato F, Cilla S, Macchia G, Torre G, Caravatta L, Mariano G, Mignogna S, Ferro M, Mattiucci GC, Balducci M, Frascino V, Piermattei A, Ferrandina G, Valentini V, Morganti AG. Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2). Clin Oncol (R Coll Radiol) 2014;26:748-56. [PMID: 25175042 DOI: 10.1016/j.clon.2014.08.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
36 Menoux I, Antoni D, Mazzara C, Labani A, Charloux A, Quoix E, Falcoz PE, Truntzer P, Noël G. Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma. Cancer Radiother 2020;24:120-7. [PMID: 32173269 DOI: 10.1016/j.canrad.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Yang H, Wang L, Shao G, Dong B, Wang F, Wei Y, Li P, Chen H, Chen W, Zheng Y, He Y, Zhao Y, Du X, Sun X, Wang Z, Wang Y, Zhou X, Lai X, Feng W, Shen L, Qiu G, Ji Y, Chen J, Jiang Y, Liu J, Zeng J, Wang C, Zhao Q, Yang X, Hu X, Ma H, Chen Q, Chen M, Jiang H, Xu Y. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. Front Oncol 2022;12:967360. [DOI: 10.3389/fonc.2022.967360] [Reference Citation Analysis]
38 Rauschenbach BM, Mackowiak L, Malhotra HK. A dosimetric comparison of three-dimensional conformal radiotherapy, volumetric-modulated arc therapy, and dynamic conformal arc therapy in the treatment of non-small cell lung cancer using stereotactic body radiotherapy. J Appl Clin Med Phys 2014;15:4898. [PMID: 25207575 DOI: 10.1120/jacmp.v15i5.4898] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
39 Frerker B, Hildebrandt G. Distinguishing Radiation Pneumonitis from Local Tumour Recurrence Following SBRT for Lung Cancer

]]>. RMI 2020;Volume 13:1-23. [DOI: 10.2147/rmi.s176901] [Reference Citation Analysis]
40 Jang SS, Shin Y, Park SY, Huh GJ, Yang YJ. Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non-small cell lung cancer. Thorac Cancer 2021. [PMID: 34689429 DOI: 10.1111/1759-7714.14203] [Reference Citation Analysis]
41 Guerreiro NFC, Araujo-Filho JAB, Horvat N, Lee HJ, Oliveira BSP, Ynoe de Moraes F, Castro I, Miranda Degrande FA, Abreu CEV, Giassi KS. Interobserver Variability in the Computed Tomography Assessment of Pulmonary Injury and Tumor Recurrence After Stereotactic Body Radiotherapy. J Thorac Imaging 2020;35:302-8. [PMID: 32168165 DOI: 10.1097/RTI.0000000000000495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Moran A, Daly ME, Yip SSF, Yamamoto T. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy. Clin Lung Cancer 2017;18:e425-31. [PMID: 28623121 DOI: 10.1016/j.cllc.2017.05.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
43 Fogliata A, Nicolini G, Clivio A, Vanetti E, Cozzi L. Accuracy of Acuros XB and AAA dose calculation for small fields with reference to RapidArc ® stereotactic treatments: Acuros for stereotactic treatments. Med Phys 2011;38:6228-37. [DOI: 10.1118/1.3654739] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
44 Roy SF, Louie AV, Liberman M, Wong P, Bahig H. Pathologic response after modern radiotherapy for non-small cell lung cancer. Transl Lung Cancer Res 2019;8:S124-34. [PMID: 31673516 DOI: 10.21037/tlcr.2019.09.05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
45 Herter-Sprie GS, Koyama S, Korideck H, Hai J, Deng J, Li YY, Buczkowski KA, Grant AK, Ullas S, Rhee K, Cavanaugh JD, Neupane NP, Christensen CL, Herter JM, Makrigiorgos GM, Hodi FS, Freeman GJ, Dranoff G, Hammerman PS, Kimmelman AC, Wong KK. Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer. JCI Insight 2016;1:e87415. [PMID: 27699275 DOI: 10.1172/jci.insight.87415] [Cited by in Crossref: 64] [Cited by in F6Publishing: 77] [Article Influence: 10.7] [Reference Citation Analysis]
46 Hu XY, Fang XM, Chen HW, Yao XJ, Qian PY, Zhou JY, Guo J, Lerner A, Hu CH. Early detection of acute radiation-induced lung injury with multi-section CT perfusion imaging: An initial experience. Clin Radiol 2014;69:853-60. [PMID: 24837694 DOI: 10.1016/j.crad.2014.03.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
47 Herrmann T, Geyer P, Appold S. The mean lung dose (MLD) : predictive criterion for lung damage? Strahlenther Onkol 2015;191:557-65. [PMID: 25865281 DOI: 10.1007/s00066-015-0833-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
48 Giglioli FR, Clemente S, Esposito M, Fiandra C, Marino C, Russo S, Strigari L, Villaggi E, Stasi M, Mancosu P. Frontiers in planning optimization for lung SBRT. Physica Medica 2017;44:163-70. [DOI: 10.1016/j.ejmp.2017.05.064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
49 Colnot J, Barraux V, Loiseau C, Berejny P, Batalla A, Gschwind R, Huet C. A new Monte Carlo model of a Cyberknife® system for the precise determination of out-of-field doses. Phys Med Biol 2019;64:195008. [PMID: 31387085 DOI: 10.1088/1361-6560/ab38e5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: History and updated role. Lung Cancer 2015;90:388-96. [DOI: 10.1016/j.lungcan.2015.10.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]